Ernexa Therapeutics (ERNAW) Deferred Taxes (2010 - 2020)
Ernexa Therapeutics' (ERNAW) quarterly Deferred Taxes came in at $13000.0 in Q4 2020, down 80.6% YoY from $67000.0 in Q1 2020, and down 61.76% on a QoQ basis from $34000.0 in Q1 2020.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Deferred Taxes (2010 - 2020) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 11 years of Deferred Taxes data on file, last reported at $13000.0 in Q4 2020.
- Quarterly Deferred Taxes fell 80.6% year-over-year to $13000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $151000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $202000.0, up 33.77% from the prior year.
- Deferred Taxes declined to $13000.0 in Q4 2020, from $34000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $148000.0 in Q1 2018 to a low of -$19000.0 in Q3 2017.
- A 5-year average of $61277.8 and a median of $51500.0 in 2017 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2017 — Deferred Taxes plunged 113.57% — and 2018, when it surged 4200.0%.
- Tracing ERNAW's Deferred Taxes over 5 years: stood at $144000.0 in 2016, then plunged by 34.72% to $94000.0 in 2017, then tumbled by 52.13% to $45000.0 in 2018, then soared by 48.89% to $67000.0 in 2019, then plunged by 80.6% to $13000.0 in 2020.
- The last three Deferred Taxes figures came in at $13000.0 (Q4 2020), $34000.0 (Q1 2020), and $67000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 13,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Dec 31, 2019 | 67,000.00 |
| Sep 30, 2019 | 37,000.00 |
| Jun 30, 2019 | 50,000.00 |
| Mar 31, 2019 | -3,000.00 |
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 71,000.00 |
| Jun 30, 2018 | 86,000.00 |
| Mar 31, 2018 | 148,000.00 |
| Dec 31, 2017 | 94,000.00 |
| Sep 30, 2017 | -19,000.00 |
| Jun 30, 2017 | 2,000.00 |
| Mar 31, 2017 | 53,000.00 |
| Dec 31, 2016 | 144,000.00 |
| Sep 30, 2016 | 140,000.00 |
| Jun 30, 2016 | 112,000.00 |
| Mar 31, 2016 | 29,000.00 |
| Dec 31, 2015 | 11,000.00 |
| Sep 30, 2015 | -45,000.00 |